Stockscreener 앱 받기
1.38
5.48%
-0.08
시간 외 거래:
1.40
0.02
+1.45%
전일 마감가:
$1.46
열려 있는:
$1.44
하루 거래량:
553.31K
Relative Volume:
0.85
시가총액:
$92.64M
수익:
-
순이익/손실:
$-46.12M
주가수익비율:
-1.5969
EPS:
-0.8642
순현금흐름:
$-41.02M
1주 성능:
-16.87%
1개월 성능:
-12.66%
6개월 성능:
-20.23%
1년 성능:
-12.66%
1일 변동 폭
$1.32
$1.48
1주일 범위
$1.30
$1.65
52주 변동 폭
$0.7113
$2.815
Inflarx N V Stock (IFRX) Company Profile
IFRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IFRX
Inflarx N V
|
1.38 | 98.91M | 0 | -46.12M | -41.02M | -0.8642 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Inflarx N V Stock (IFRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-02 | 재개 | H.C. Wainwright | Buy |
| 2025-05-29 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-04-05 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-02-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-10-28 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-03-11 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-11-06 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-10-08 | 개시 | H.C. Wainwright | Buy |
| 2020-06-17 | 개시 | BTIG Research | Buy |
| 2020-04-30 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2019-06-05 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2019-06-05 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-06-05 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2019-06-05 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-06-05 | 다운그레이드 | SunTrust | Buy → Hold |
| 2019-01-29 | 개시 | Robert W. Baird | Outperform |
| 2018-12-10 | 개시 | Credit Suisse | Outperform |
| 2018-07-13 | 개시 | BMO Capital Markets | Outperform |
| 2018-06-28 | 개시 | Raymond James | Outperform |
| 2018-06-28 | 개시 | SunTrust | Buy |
| 2018-02-08 | 개시 | B. Riley FBR, Inc. | Buy |
모두보기
Inflarx N V 주식(IFRX)의 최신 뉴스
Will InflaRx N.V. stock see PE expansionWeekly Trade Analysis & Consistent Profit Trade Alerts - newser.com
Will InflaRx N.V. (IF0) stock outperform benchmarksWeekly Trend Summary & Safe Entry Point Alerts - newser.com
Why InflaRx N.V. (IF0) stock benefits from AI revolutionJuly 2025 Trends & Weekly Setup with ROI Potential - newser.com
Why InflaRx N.V. stock is considered a top pickJuly 2025 Patterns & Verified Chart Pattern Trade Signals - newser.com
Why InflaRx N.V. stock remains a top recommendationTrade Entry Summary & Detailed Earnings Play Strategies - newser.com
Can InflaRx N.V. recover in the next quarter2025 Trading Recap & Risk Controlled Swing Alerts - newser.com
Will InflaRx N.V. (IF0) stock deliver compounding returnsJuly 2025 PreEarnings & Real-Time Price Movement Reports - newser.com
How geopolitical tensions affect InflaRx N.V. stockBear Alert & Risk Managed Investment Strategies - newser.com
Institutional scanner results for InflaRx N.V.Weekly Market Report & Daily Technical Stock Forecast Reports - newser.com
Total debt per share of InflaRx N.V. – MUN:IF0 - TradingView
Reversal indicators forming on InflaRx N.V. stock2025 Sector Review & Daily Chart Pattern Signal Reports - newser.com
How InflaRx N.V. stock performs after earningsGap Up & Safe Capital Allocation Plans - newser.com
Volatility clustering patterns for InflaRx N.V.Recession Risk & Technical Pattern Recognition Alerts - newser.com
InflaRx NV IF0 Stock Analysis and ForecastEarnings Growth Projections & Learn to Think Like a Long-Term Investor - earlytimes.in
InflaRx N.V. (NASDAQ:IFRX) Short Interest Update - MarketBeat
How reliable is InflaRx N.V. (IF0) stock dividend growthIPO Watch & Daily Profit Maximizing Tips - newser.com
Can InflaRx N.V. stock rebound after recent weaknessTrade Volume Summary & Daily Chart Pattern Signals - newser.com
Will InflaRx N.V. (IF0) stock deliver stable dividends2025 Winners & Losers & High Win Rate Trade Tips - newser.com
What hedge fund moves indicate for InflaRx N.V. (IF0) stockJuly 2025 Review & Real-Time Chart Breakout Alerts - newser.com
Edesa Biotech and InflaRx: Advancing ARDS Treatment with Vilobelimab - MSN
InflaRx’s Phase 2a Study on INF904: A Potential Game-Changer for Chronic Conditions - MSN
Edesa Biotech and InflaRx: Breathing New Life into ARDS Treatment - MSN
InflaRx N.V. (NASDAQ:IFRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Why InflaRx N.V. stock remains resilient2025 Investor Takeaways & Weekly Watchlist for Consistent Profits - fcp.pa.gov.br
Edesa Biotech and InflaRx: Advancing ARDS Treatment with Bevacizumab - MSN
Inflarx N V (IFRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.64%
0.35%
자본화:
|
볼륨(24시간):